- Report
- August 2024
- 137 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- August 2024
- 100 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 119 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- February 2025
- 390 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 53 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- November 2024
- 90 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- September 2022
- 317 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- June 2023
- 100 Pages
Europe
From €4278EUR$4,500USD£3,594GBP
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2023
- 212 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- November 2023
- 175 Pages
From €3280EUR$3,450USD£2,755GBP

The AI in Life Sciences market pertains to the application of artificial intelligence technologies within the field of biotechnology to advance research, drug discovery, personalized medicine, and diagnostic processes. This interdisciplinary collaboration bridges computational methods, such as machine learning, natural language processing, and image recognition, with molecular biology, genomics, and biopharmaceutical development. AI-driven tools are employed for analyzing complex biological data, predicting molecular behavior, and accelerating the development of new therapies by identifying potential drug candidates more efficiently than traditional methods. The use of AI in life sciences also extends to enhancing clinical trial design, patient monitoring, and improving the accuracy of diagnostics through advanced pattern recognition in medical imaging. The integration of AI into biotechnology is reshaping the landscape of life science research by enabling the handling and interpretation of the vast amounts of data generated in modern biological experiments and enhancing the precision of biomedical applications.
Within this market, several players have emerged as front-runners. Companies like Deep Genomics leverage AI for genomic medicine, while Recursion Pharmaceuticals uses it for drug discovery. Insitro and Atomwise apply AI to identify novel drug candidates, and PathAI focuses on improving diagnostic accuracy in pathology. Other notable companies in the space include BenevolentAI, which applies AI to understand diseases and discover potential drugs, and Verge Genomics, which uses AI to analyze genetic data for neurodegenerative diseases. Show Less Read more